23 December 2019 1 Min Read
Nod for schizophrenia drug with no jitters
The US drugs regulator approves Caplyta, which in trials did not cause uncomfortable akathisia sensations
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In